Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Steven
Advertisement
Articles by Steven
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
New CKD Outcome Set Tells Pharmacists What to Measure
2
FDA Approves Zilganersen Injection, First Drug for Alexander Disease
3
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
4
The PBM Reform Clock Is Running to 2028—Here's What Independent Pharmacies Should Do
5